Company profile · Basel, Switzerland

Sandoz

Generics, Biosimilars, and Global Essential-Medicines Supply · Global regulated medicines supply

Basel headquarters node coordinating generics and biosimilars governance across the wider European manufacturing network.

Lead
Richard Saynor (verified ↗)
Address
Lichtstrasse 35, CH-4056 Basel, Switzerland (source ↗)
Compliance
GMP medicines manufacturing
Last reviewed
14 Mar 2026 (3mo ago)
Scale
Global regulated medicines supply
Capabilities
Generics Manufacturing · Biosimilars Supply · Commercial Medicines Operations
Founded
1886
Headcount
10000+
LinkedIn
Company page (open ↗)
Site and address
Clinical profileSTATUS: VERIFIED MARCH 2026

Richard Saynor

Chief Executive Officer

Check official leadership source
Full addressLichtstrasse 35, CH-4056 Basel, Switzerland
Site coordinates47.572839, 7.579452
Review cycleMay 2026
Physical site source

Official Sandoz corporate contact page listing Lichtstrasse 35, Basel.

Open source
Operating profile

Global regulated medicines supply

Basel, Switzerland. Generics, Biosimilars, and Global Essential-Medicines Supply. Review completed on 14 Mar 2026.

2026 technical specializationGenerics, Biosimilars, and Global Essential-Medicines Supply
Core capabilities
Generics ManufacturingBiosimilars SupplyCommercial Medicines Operations
Governance

Swiss, EMA, FDA, and global medicines oversight

GMP medicines manufacturing, Global generics and biosimilars quality systems

Editorial note

Generics, Biosimilars, and Global Essential-Medicines Supply

Basel headquarters node coordinating generics and biosimilars governance across the wider European manufacturing network.

Related companies
Editorial note

Sandoz broadens the Swiss cluster layer with a current executive record and a public business surface centered on generics and biosimilars.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026Last reviewed: 14 March 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

Generics Manufacturing
Biosimilars Supply
Commercial Medicines Operations
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidenceSandoz official corporate-governance page confirming Richard Saynor as CEO.Source origin: sandoz.comOpen source
Supporting evidenceSandoz official business surface outlining the manufacturing and medicines platform.Source origin: sandoz.comOpen source
Physical-site evidenceOfficial Sandoz corporate contact page listing Lichtstrasse 35, Basel.Source origin: sandoz.comOpen source
Infrastructure

Declared infrastructure

Medicines production network
Commercial quality systems
Analytical governance tools
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
VERIFIED ACTIVE 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is Sandoz located?
Sandoz operates from Lichtstrasse 35, CH-4056 Basel, Switzerland, Basel, Switzerland.
Who runs Sandoz?
Sandoz is led by Richard Saynor, Chief Executive Officer. Verified 14 Mar 2026.
What certifications does Sandoz hold?
Sandoz is documented under GMP medicines manufacturing.
What does Sandoz do?
Basel headquarters node coordinating generics and biosimilars governance across the wider European manufacturing network. Core capabilities: Generics Manufacturing, Biosimilars Supply, Commercial Medicines Operations.
Editorial context

Related technical briefs

Briefs that name Basel as a covered market or city.